US Stock Market Update | Chinese pharmaceutical stocks buck the trend and fall, HUTCHMED drops more than 4%

According to Zhitong Finance, on Monday, Chinese concept pharmaceutical stocks fell against the market. As of the time of publication, Zai Lab dropped more than 3.8%, Hutchmed China fell more than 4%, and Beigene slightly declined

According to CNBC, on Monday, Chinese pharmaceutical stocks fell against the market trend. As of the time of publication, Zai Lab (ZLAB.US) dropped more than 3.8%, Hutchmed China (HCM.US) dropped more than 4%, and Beigene (BGNE.US) slightly declined

Source: Zhitong The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.